FDA: New Steps to improve Supply Chain Security

Recommendation
21/22 May 2025
Munich, Germany
The FDA supports the adoption of more modern technologies for improving the security of the drug supply chain. Innovations should improve tracking and tracing of medicines.
Now FDA is launching a new pilot project in which participants representing the drug supply chain (e.g., manufacturers, repackagers and other stakeholders) can pilot the use of innovative and emerging approaches for enhanced tracing and verification. Currently the project is focusing on prescription drugs in the U.S., with the aim to prevent suspicious and illegitimate products from entering the supply chain.
The intention of the so-called "Pilot Project Program Under the Drug Supply Chain Security Act" (DSCSA Pilot Project Program) is to assist FDA and members of the pharmaceutical distribution supply chain in the development of an electronic, interoperable system.
Related GMP News
14.05.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
13.05.2025Survey on GDP Implementation
13.05.2025New Version of the HPRA GDP Guide Published
13.05.2025GDP in the US: Updates on Implementation of DSCSA
13.05.2025GDP Non-Compliance Report: No Responsible Person, proper Storage and Distribution not ensured
13.05.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 2